Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell

Journal of Sichuan University (Medical Science)

Volumn 37, Issue 5, 2006, Pages 757-760

  Wang, Hong Jing ^a   Liu, Kiao Jing ^a   Yang, Kai Xuan ^a   Luo, Feng Ming ^a   Lou, Jiang Yan ^a   Peng, Zhi Lan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Celecoxib; Cyclooxygenase 2; Nonsteroidal anti inflammatory drugs; Ovarian neoplasm

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 33749615327     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Li S, Miner K, Fannin R, et al. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol Oncol, 2004;92(2):622-627.
2. Munkarah AR, Morris R, Baumann P, et al. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Investig, 2002;9(3):168-173.
3. Jaime LM, Kathleen ML, Alane TK, et al. Antiangiogentic and antitumor of cyclooxygenase2 inhibitors. Cancer Res, 2000;60:1306-1311.
4. Noda M, Tataumni Y, Tomizawa M, et al. Effecta of etodolac a selecsive COX-2 inhibitor: on the expression of E-Cadherin-Catenin complex in gastrointestinal cell line. J Gastroentend, 2002;37(11):86-904.
5. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis(part I). J Natl Cancer Inst, 1998;90(2)1529-1536.
6. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 1994;107: 1183-1188.
7. Grosch S, Tegeter I, Niederberger E, et al. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor Celecoxib. FASEB J, 2001;15(4):2742-2744.
8. Alfonso Catalano, Laura Graciotti, Luciana Rinaldi, et al. Reclinical evaluation of the nonsteroidal anti-inflammatory agent Celecoxib on malignant mesothelioma chemoprevention. Int J Cancer, 2004;109:322-328.